A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis
暂无分享,去创建一个
Ying Sun | Zheng Zhang | Z. Zou | R. Xu | Jun‐liang Fu | M. Shi | Fu-Sheng Wang | Baosen Li | Jin Li | Lifeng Wang | Honghong Liu | Yuan-yuan Li | Hu Lin | Liming Chen | Sa Lv | Si-yu Wang | Fu-Sheng Wang
[1] Zheng Zhang,et al. Human Mesenchymal Stem Cell Transfusion Is Safe and Improves Liver Function in Acute‐on‐Chronic Liver Failure Patients , 2012, Stem cells translational medicine.
[2] Yu-feng Yin,et al. B cell depletion in treating primary biliary cirrhosis: pros and cons. , 2012, World journal of gastroenterology.
[3] K. Lindor,et al. Pathogenesis and management of pruritus in cholestatic liver disease , 2012, Journal of gastroenterology and hepatology.
[4] K. Tsuneyama,et al. Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody–positive versus antimitochondrial autoantibody–negative primary biliary cirrhosis , 2012, Hepatology.
[5] F. Xue,et al. Immunosuppressive function of mesenchymal stem cells from human umbilical cord matrix in immune thrombocytopenia patients , 2012, Thrombosis and Haemostasis.
[6] Lei Jin,et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients , 2012, Journal of gastroenterology and hepatology.
[7] K. Lindor,et al. Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid , 2012, Hepatology.
[8] M. Roma,et al. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. , 2011, Clinical science.
[9] M. Kay,et al. Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells , 2011, Cell transplantation.
[10] Natalie J. Wood. Primary biliary cirrhosis: Fenofibrate plus UDCA promising for incomplete responders to UDCA , 2011, Nature Reviews Gastroenterology &Hepatology.
[11] R. Mu,et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis , 2010, Arthritis Research & Therapy.
[12] Dandan Wang,et al. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. , 2010, Arthritis and rheumatism.
[13] M. Kaplan,et al. Methotrexate in Patients with Primary Biliary Cirrhosis Who Respond Incompletely to Treatment With Ursodeoxycholic Acid , 2010, Digestive Diseases and Sciences.
[14] L. Hynan,et al. The 5‐D itch scale: a new measure of pruritus , 2010, The British journal of dermatology.
[15] U. Neumann,et al. Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation? , 2008, Annals of transplantation.
[16] S. Kyurkchiev,et al. Characterization of mesenchymal stem cells isolated from the human umbilical cord , 2008, Cell biology international.
[17] A. Nauta,et al. Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.
[18] W. März,et al. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid , 2007, Hepatology.
[19] C. Steer,et al. Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid. , 2007, Current issues in molecular biology.
[20] J. Rodés,et al. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. , 2006, Gastroenterology.
[21] S. Perez,et al. Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells , 2006, Stem cells.
[22] Ji-Ye Cai,et al. [Directional differentiation of embryonic stem cells into biliary epithelium cells in vitro: an experiment with mice]. , 2005, Zhonghua yi xue za zhi.
[23] Yi Zhang,et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. , 2005, Blood.
[24] R. Schwartz,et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. , 2002, The Journal of clinical investigation.
[25] S. Bruder,et al. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.
[26] T. Therneau,et al. Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid , 2000, Hepatology.
[27] W. Janssen,et al. Adult Bone Marrow Stromal Cells Differentiate into Neural Cells in Vitro , 2000, Experimental Neurology.
[28] E. Dickson,et al. Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid , 2000, Hepatology.
[29] C. Dietrich,et al. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment , 2000, Gut.
[30] D. Stewart,et al. Fatigue in primary biliary cirrhosis , 1998, Gut.
[31] K. Batts,et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation , 1997, Hepatology.
[32] E A Jones,et al. Application of piezo film technology for the quantitative assessment of pruritus. , 1991, Biomedical instrumentation & technology.
[33] P. Grambsch,et al. Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.
[34] K. Lazaridis,et al. Primary biliary cirrhosis , 1998, Springer Netherlands.
[35] T. Marrie,et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.